Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabienne Thomas

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Pharmacological Research|November 29, 2016
Reply to the letter addressed by Amr A. EL-Arabey "Dual function of OCT-2 and MATE1 in Cisplatin induced nephrotoxicity"Fabienne Thomas
Therapie|March 7, 2017
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of PharmacogeneticsSylvie Quaranta, Fabienne Thomas
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2020
Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a reviewMaud Maillard, Félicien Le Louedec, Fabienne Thomas, et al.
Therapie|June 22, 2007
[Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys]Fabienne Thomas, Sophie Séronie-Vivien, Laurence Malard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Ototoxicity of high-dose carboplatinChristine Chevreau, Fabienne Thomas, Corinne Couteau, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2025
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophyMatthieu Gracia, Sabrina Marsili, Julien Vintejoux, et al.
Therapie|December 19, 2021
Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescriptionMaud Maillard, Baptiste Louveau, Paul Vilquin, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2021
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayrFélicien Le Louedec, Florent Puisset, Fabienne Thomas, et al.
Pharmacogenomics|December 15, 2010
Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresisFabienne Thomas, Janelle M Hoskins, Anne Dvorak, et al.
Medical Oncology (Northwood, London, England)|April 29, 2006
Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patientsSophie Séronie-Vivien, Stéphanie Toullec, Laurence Malard, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Pharmacological Research|November 29, 2016
Reply to the letter addressed by Amr A. EL-Arabey "Dual function of OCT-2 and MATE1 in Cisplatin induced nephrotoxicity"Fabienne Thomas
Therapie|March 7, 2017
Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of PharmacogeneticsSylvie Quaranta, Fabienne Thomas
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2020
Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a reviewMaud Maillard, Félicien Le Louedec, Fabienne Thomas, et al.
Therapie|June 22, 2007
[Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys]Fabienne Thomas, Sophie Séronie-Vivien, Laurence Malard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Ototoxicity of high-dose carboplatinChristine Chevreau, Fabienne Thomas, Corinne Couteau, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2025
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophyMatthieu Gracia, Sabrina Marsili, Julien Vintejoux, et al.
Therapie|December 19, 2021
Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescriptionMaud Maillard, Baptiste Louveau, Paul Vilquin, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 3, 2021
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayrFélicien Le Louedec, Florent Puisset, Fabienne Thomas, et al.
Pharmacogenomics|December 15, 2010
Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresisFabienne Thomas, Janelle M Hoskins, Anne Dvorak, et al.
Medical Oncology (Northwood, London, England)|April 29, 2006
Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patientsSophie Séronie-Vivien, Stéphanie Toullec, Laurence Malard, et al.
Pageof 9